期刊文献+

1例重症肺炎伴脓毒血症患者万古霉素个体化给药方案分析 被引量:3

Individualized dosing regimen of vancomycin for 1 patient with severe pneumonia and sepsis
下载PDF
导出
摘要 临床药师对1例重症肺炎伴脓毒血症患者使用万古霉素后进行血药浓度监测,多次调整剂量,患者血药浓度仍低于有效浓度,病情反复。通过查阅文献,结合患者多次血药浓度监测结果,临床药师建议将传统间歇滴注给药方式改为24 h微电脑静脉输液泵持续静脉滴注给药,在不超过最大日剂量的同时,患者血药浓度维持在18~24μg·mL-1,较好地发挥了万古霉素的疗效,患者病情好转。临床药师结合抗菌药物PK/PD理论,优化万古霉素给药方案,为患者提供了有效的药学服务。 Clinical pharmacists monitored the blood concentration of vancomycin in 1patient with severe pneumonia and sepsis,and adjusted the dose many times,but the concentration of blood drug was still lower than the effective concentration range.Clinical pharmacists suggested that the traditional intermittent infusion method should be changed into 24hour microcomputers by consulting the literature.The blood concentration of the patient was maintained at 18-24μg·mL^-1,within the maximum daily dose of vancomycin,the effect ofvancomycin and the patient's condition were improved.Clinical pharmacists combined with PK/PD theory of antibacterial drugs to optimize the vancomycin dosage regimen and provided effective pharmaceutical care for patients.
作者 史群志 鲁虹 李玲 刘芳群 SHI Qun-zhi;LU Hong;LI Ling;LIU Fang-qun(Changsha Central Hospital,Changsha 410000)
机构地区 长沙市中心医院
出处 《中南药学》 CAS 2018年第12期1777-1780,共4页 Central South Pharmacy
关键词 万古霉素 重症肺炎 脓毒血症 个体化给药 静脉持续滴注 vancomycin severe pneumonia sepsis individualized administration continuous intravenous infusion
  • 相关文献

参考文献7

二级参考文献41

  • 1王辉,孙宏莉,陈民钧,刘勇,俞云松,胡云健,胡必杰,倪语星,席云,孙自镛,沈定霞,徐英春,谢秀丽.2005—2006年我国九家教学医院分离的常见呼吸道病原菌的耐药监测研究[J].中华检验医学杂志,2007,30(11):1242-1247. 被引量:31
  • 2McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the in- hibitory curve (AUIC) and time above the minimum inhibitory concentratio (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections [ J ]. Int J Antimicrob Agents, 2008,31 (4) : 345 - 351.
  • 3Kuti JL,Nightingale CH,Knauft RF,et al. Pharmacokinetic properties and stability of continuous - infusion meropenem in adults with cystic fibrosis [J]. Clinical Therapeutics, 2004,26 (4) : 493 - 501.
  • 4Trissel LA, Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y - site administration with other drugs and in- fusion solutions[J]. J Am Pharm Assoc (Wash) ,2000,40(4): 515 - 519.
  • 5Woznica R, Ferenc K, Kurec D. Cefoperazone/sulbactam in continuous in- fusion[J]. Anestezjol Intens Ter,2010,42(2) : 80 - 84.
  • 6Hubert D, Le Roux E, Lavrut T, et al. Continuous versus intermittent infu- sions of ceftazidime for treating exacerbation of cystic fibrosis[J]. Antimi- Crobial Agents and Chemotherapy, 2009,53 (3) : 3 650 - 3 656.
  • 7Raverdy V, Ampe E, Hecq JD, et al. Stability and compatibility of vancomycin for administration by continuous infusion[J]. J antimicrob Chemother,2013,68(5): 1 179 - 1 182.
  • 8Roberts JA, Webb S, Paterson D, et al. A systematic review on clinical ben- efits of continuous administration of beta -lactam antibiotics[J]. Crit Care Med,2009,37(6): 2 071 -2 078.
  • 9Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective muhicenter randomized study[J]. Antimicrob Agents Chemother, 2001, 45 (9) : 2 460 - 2 467.
  • 10国家食品药品监督管理局.注射用盐酸万古霉素药品说明书[S].2006:11.

共引文献800

同被引文献34

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部